Plain-English translation of NCT07071714 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called SHR-8068 in combination with standard anti-tumor treatments for colorectal cancer. The study wants to understand whether this medication is safe, well-tolerated, and effective when given alongside existing cancer therapies. Researchers will enroll about 103 people to see how the treatment works.
Colorectal cancer remains a serious disease, and doctors are always looking for new ways to improve treatment outcomes. This medication may help enhance the effectiveness of current cancer therapies or make them work better for patients.
You would receive SHR-8068 as an injection alongside your standard anti-cancer treatment. The trial has two parts: Part A is designed for people with a longer life expectancy, while Part B is for those with more advanced disease. You'll need to visit the clinic regularly for treatment, blood tests, and imaging to monitor how you're responding and to check for any side effects.
AI-generated summary from trial data · Aug 13, 2026 · Not medical advice
China